| 59417-101 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-101 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-101 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-101 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-101 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-101 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-102 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-102 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-102 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-102 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-102 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-102 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-103 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-103 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-103 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-103 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-103 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-103 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-104 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-104 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-104 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-104 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-104 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-104 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-105 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-105 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-105 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-105 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-105 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-105 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-106 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-106 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-106 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-106 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-106 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-106 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-107 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-107 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-107 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-107 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |
| 59417-107 | Vyvanse | lisdexamfetamine dimesylate | Takeda Pharmaceuticals America, Inc. | NDA | Current |
| 59417-107 | Vyvanse | lisdexamfetamine dimesylate | Shire LLC | NDA | Current |